Jan 11, 2023 / 05:00PM GMT
Ruizhi Qin - JPMorgan Chase & Co, Research Division - Analyst
All right. Good morning, everyone. Welcome to day 3 of the JPMorgan Healthcare Conference. I'm Julia Qin, lead analyst covering life science tools and diagnostics at JPMorgan, and it's my great pleasure to introduce you to our next company presentation by Invitae.
So Ken, the stage is yours.
Kenneth D. Knight - Invitae Corporation - President, CEO & Director
Thank you, Julia, and I appreciate the opportunity to join everyone today, and thanks to you and your team, by the way. I think you're putting together another great conference.
Good morning, everyone, and thank you for joining us. With me today is Dr. Bob Nussbaum, our Chief Medical Officer; and Roxi Wen, our Chief Financial Officer. They're excited to be here, as you can tell by looking at them.
Looking back to 2022, it was a year of significant changes in foundational progress at itvitae. And I appreciate the opportunity to update the investment community on our story as we begin a new year. Before I start,
Invitae Corp at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot